Aspects of prostaglandin function in the lung (second of two parts).

Lung defense mechanisms (second of two parts).

Gastrin (second of two parts).

Histamine (second of two parts).

The cancer cell: dynamic aspects and modification in cell-surface organization (second of two parts).

Bronchodilator therapy (second of two parts).

Renal transplantation (second of two parts).

Clinical pharmacokinetics (second of two parts).

Polymyositis and dermatomyositis (second of two parts).

The pathogenesis of atherosclerosis (second of two parts).

Clinical pharmacology of oral antidiabetic agents (second of two parts).

Vasodilator therapy of cardiac failure (second of two parts).

Lung defense mechanisms (first of two parts).

Catecholamines and neurologic diseases (second of two parts).

Oxygen-dependent microbial killing by phagocytes (second of two parts).

Drug therapy: antiplatelet therapy (second of two parts).

The efficacy of intramuscular 15 methyl prostaglandin E2 in second-trimester abortion. Coagulation and hormonal aspects.

Treatment of congenital deformities of the hand and forearm (second of two parts).

The biosynthesis of collagen and its disorders (second of two parts).

The reliability of clinical methods, data and judgments (second of two parts).

Current concepts in genetics: principles of medical genetics (second of two parts).

Regulation of respiration: (second of three parts).

Nerve growth factor (second of three parts).

Cellular mechanisms for lipid deposition in atherosclerosis (second of two parts).

Chlamydial infections (second of three parts).

Suggest Documents

Lung defense mechanisms (second of two parts).

Gastrin (second of two parts).

Histamine (second of two parts).

The cancer cell: dynamic aspects and modification in cell-surface organization (second of two parts).

Bronchodilator therapy (second of two parts).

Renal transplantation (second of two parts).

Clinical pharmacokinetics (second of two parts).

Polymyositis and dermatomyositis (second of two parts).

The pathogenesis of atherosclerosis (second of two parts).

Clinical pharmacology of oral antidiabetic agents (second of two parts).

Vasodilator therapy of cardiac failure (second of two parts).

Lung defense mechanisms (first of two parts).

Catecholamines and neurologic diseases (second of two parts).

Oxygen-dependent microbial killing by phagocytes (second of two parts).

Drug therapy: antiplatelet therapy (second of two parts).

The efficacy of intramuscular 15 methyl prostaglandin E2 in second-trimester abortion. Coagulation and hormonal aspects.

Treatment of congenital deformities of the hand and forearm (second of two parts).

The biosynthesis of collagen and its disorders (second of two parts).

The reliability of clinical methods, data and judgments (second of two parts).

Current concepts in genetics: principles of medical genetics (second of two parts).

Regulation of respiration: (second of three parts).

Nerve growth factor (second of three parts).

Cellular mechanisms for lipid deposition in atherosclerosis (second of two parts).

Chlamydial infections (second of three parts).

Aspects of prostaglandin function in the lung (second of two parts).

Recommend Documents

Follow Us